Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 276 No 7397 p486
22 April 2006


Society summary


Broad remit for museum acquisitions is restored

An updated acquisitions and disposals policy for the museum of the Royal Pharmaceutical Society restores its former comprehensive collecting remit following a four-year period in which collecting has been restricted to proprietary medicines, materia medica and items from the Society's history.

The revised policy was approved at the April Council meeting on the recommendation of the Science Committee. As well as reinstating a comprehensive collecting remit, the policy update aims to reflect the museum’s current practice and retain compliance with current and forthcoming national standards. Among other things, it takes into account the features of a model acquisitions and disposals policy required by the Museums, Libraries and Archives Council’s accreditation standard, with which the museum will need to comply from 2008 if it is to meet a new accreditation standard that will replace its current registration.

The museum will continue to maintain its main focus in areas where it is deemed to be the only British museum currently holding and regularly updating a systematic connection. These areas are:

· Contemporary, recent and historical proprietary and other medicines, including related promotional or other material of particular medical, social or political historical significance

· Controlled Drugs, fulfilling all requirements necessary to the continuing renewal of its licence to be in possession and authority to be in possession, granted under the Misuse of Drugs Act 1971 and Misuse of Drugs Regulations 1985 (as amended)

· Material evidence relating to the history and work of the Society

In addition, the museum will resume the collection of a full range of material evidence including artefacts, images, historical and contemporary artworks, and associated information relating to the history and practice of pharmacy in Britain (in its broadest social, political, medical, scientific and international context) and the development of the profession of pharmacy in Britain.

Acquisition will focus particularly on areas that are currently under-represented in the collection, for example, material dating before 1800 and after 1945, with special reference to contemporary objects.

In the case of medicinal or cosmetic preparations, the museum will collect two examples of each item where possible, to allow the potential for destructive testing in the future, to facilitate possible future research while taking into account all ethical implications.

As well as reintroducing collection in all areas of pharmacy history, the updated policy includes a specific statement that the museum will formally decline offers of objects with a specific regional provenance, advising donors to offer the item to the most relevant local museum in preference to taking them out of their geographical or community context.

Other features of the updated policy include updated references to legislation governing illicit trade, items that might be designated as treasure. Also incorporated into the policy is new Government guidance on retention of human remains in museums and a Museum and Galleries Commission statement of principle on “Spoliation of works of art during the Nazi, Holocaust and World War II period”.

Opening debate on the recommendation at the Council meeting, the President thanked the keeper of the museum collection, Briony Hudson, along with her team and the museum volunteers, for the quality of the museum displays within the headquarters building.

Stephen Denyer, chairman of the Science Committee, said that it was a privilege to be involved not just with what is going forward in the advance of the profession, but with the bedrock on which that science was being built. It was particularly pleasing to present the proposed new policy from a position of anticipated measured growth in the museum after a period of consolidation.

Answering a question from Douglas Simpson, Ms Hudson confirmed that there was no intention to redistribute items already in the collection to regional museums. But if the museum were offered items with local provenance rather than national significance, then a local registered museum — one with the same standards of care as the Society’s museum — should be given first refusal. The community and local context was important, particularly with material from a business or hospital that had been in a town for a long period. The museums network meant that such an item would not be lost to the Society. It could borrow items or advise an inquirer where to go to research an item.

Sylvia Hikins said she felt privileged to walk through the building and see the museum displays but she would love to see the museum reach outside to the public more, promoting pharmacy and science, particularly among young people.

Ms Hudson said that the museum’s terms of remit were as an education and outreach resource. Among other things, it lent objects for exhibitions in other museums so that they reached a wider audience. It regularly worked with its neighbour, the Museum of Gardening History, answering inquiries about medicinal plants and supporting it when it tried to add a medicinal or pharmaceutical element to its work. The museum was also working on medicinal plants with the Museum of Garden History and four other museums of medical history as part of Museums and Galleries Month, which is in May.

In terms of a schools audience, the museum hoped that the new displays in the reception area would attract small groups, although it would have to be by appointment. The museum had been working with local schools and hoped to build on its contacts and accommodate further visits. In the longer term, the museum would like to make more material available for use at a distance, through material on websites and through the development of published teachers’ packs.

Ms Hudson added that the Society had recently received a request from Goldsmiths Hall, which this summer was to have an exhibition on two goldsmiths, one of whom was the designer of the President’s chain. The President had agreed to lend the chain for the exhibition.

Ray Jobling said that the museum was a tremendous asset to the Society. He wished to emphasise that the areas currently underrepresented included materials from 1945 onwards. That was now more than 60 years ago and, with the NHS dating from 1948, it was a time of significant change. The policy of collecting recent items was a sound one.

Andrew McCoig said that he was concerned that the policy might discourage gifts or bequests from pharmacists who had something to leave that might be of historical interest.

Ms Hudson said that there was a delicate balance. Every object collected by the museum had resource implications. Once it had said “yes” to an object, the museum’s role was to keep it forever, to add it to a resource that the Society would keep in trust for the public and members for the rest of time. Therefore, before accepting an object, the museum had to be sure that it could store it safely and preserve it. And it was also clearly not a good use of the museum’s resources to have multiple examples of the same item.

Back to Top


©The Pharmaceutical Journal